Table 4 Standardised incidence ratios of second primary cancers at >60 days - 5 years

Lung (C33-34)

119

0.79

(0.65, 0.94)

105

0.69

(0.57, 0.84)

112

0.74

(0.61, 0.89)

98

0.83

(0.67, 1.01)

Colorectal (C18-20)

324

0.89

(0.80, 1.00)

301

0.83

(0.74, 0.93)

323

0.89

(0.80, 1.00)

271

0.86

(0.76, 0.97)

Female breast (C50)

363

0.96

(0.86, 1.06)

272

0.71

(0.63, 0.80)

348

0.92

(0.82, 1.02)

274

0.96

(0.85, 1.08)

 Age <50

52

2.13

(1.58, 2.78)

25

1.02

(0.65, 1.50)

49

2.00

(1.48, 2.64)

28

1.67

(1.11, 2.42)

 Age ≥50

311

0.88

(0.78, 0.98)

247

0.69

(0.61, 0.78)

299

0.84

(0.75, 0.94)

246

0.92

(0.81, 1.04)

Prostate (C61)

342

0.71

(0.63, 0.79)

339

0.70

(0.63, 0.78)

323

0.89

(0.80, 1.00)

339

0.88

(0.79, 0.98)

Head & neck (C00-C14, C30-C32)

204

1.93

(1.67, 2.21)

196

1.85

(1.60, 2.13)

201

1.90

(1.64, 2.18)

176

1.74

(1.49, 2.02)

Stomach (C16)

46

1.05

(0.77, 1.40)

43

0.98

(0.71, 1.32)

44

1.00

(0.73, 1.35)

43

1.02

(0.74, 1.38)

Bladder (C67)

140

1.41

(1.19, 1.67)

138

1.39

(1.10, 1.55)

140

1.41

(1.19, 1.67)

139

1.46

(1.23, 1.73)

Oesophagus (C15)

26

0.80

(0.52, 1.17)

25

0.77

(0.50, 1.13)

25

0.77

(0.50, 1.13)

25

0.80

(0.51, 1.18)

Melanoma (C43)

102

1.35

(1.10, 1.64)

75

0.98

(0.77, 1.23)

102

1.35

(1.10, 1.64)

75

1.01

(0.79, 1.27)

Ovarian (C56)

19

0.61

(0.36, 0.95)

18

0.58

(0.34, 0.91)

19

0.61

(0.37, 0.95)

18

0.60

(0.36, 0.95)

All of above

1685

0.96

(0.91, 1.00)

1512

0.86

(0.81, 0.90)

1637

1.00

(0.95, 1.05)

1458

0.99

(0.94, 1.04)